
CardioNet
Develops diagnostic and patient management tools for the diagnosis and treatment of patients with cardiovascular disease.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 | round | |
N/A | $81.0m | IPO | |
Total Funding | 000k |
CAD | 2019 | 2020 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 840 % |
EBITDA | 0000 | 0000 |
% EBITDA margin | (200 %) | 9 % |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by CardioNet
Edit
ACQUISITION by CardioNet Aug 2012

ACQUISITION by CardioNet Feb 2012